203 related articles for article (PubMed ID: 28337476)
1. Cerebrospinal fluid biomarker examination as a tool to discriminate behavioral variant frontotemporal dementia from primary psychiatric disorders.
Vijverberg EG; Dols A; Krudop WA; Del Campo Milan M; Kerssens CJ; Gossink F; Prins ND; Stek ML; Scheltens P; Teunissen CE; Pijnenburg YA
Alzheimers Dement (Amst); 2017; 7():99-106. PubMed ID: 28337476
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal Fluid and Plasma Biomarkers do not Differ in the Presenile and Late-Onset Behavioral Variants of Frontotemporal Dementia.
Marelli C; Hourregue C; Gutierrez LA; Paquet C; Menjot de Champfleur N; De Verbizier D; Jacob M; Dubois J; Maleska AM; Hirtz C; Navucet S; Bennys K; Dumurgier J; Cognat E; Berr C; Magnin E; Lehmann S; Gabelle A
J Alzheimers Dis; 2020; 74(3):903-911. PubMed ID: 32083577
[TBL] [Abstract][Full Text] [Related]
4. The use of synaptic biomarkers in cerebrospinal fluid to differentiate behavioral variant of frontotemporal dementia from primary psychiatric disorders and Alzheimer's disease.
Das S; van Engelen ME; Goossens J; Jacobs D; Bongers B; Fieldhouse JLP; Pijnenburg YAL; Teunissen CE; Vanmechelen E; Verberk IMW
Alzheimers Res Ther; 2024 Feb; 16(1):34. PubMed ID: 38355535
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid neurofilament light chain differentiates behavioural variant frontotemporal dementia progressors from non-progressors.
Eratne D; Keem M; Lewis C; Kang M; Walterfang M; Farrand S; Loi S; Kelso W; Cadwallader C; Berkovic SF; Li QX; Masters CL; Collins S; Santillo A; Velakoulis D;
J Neurol Sci; 2022 Nov; 442():120439. PubMed ID: 36201960
[TBL] [Abstract][Full Text] [Related]
6. Disease trajectories in behavioural variant frontotemporal dementia, primary psychiatric and other neurodegenerative disorders presenting with behavioural change.
Reus LM; Vijverberg EG; Tijms BM; Kate MT; Gossink F; Krudop WA; Campo MD; Teunissen CE; Barkhof F; van der Flier WM; Visser PJ; Dols A; Pijnenburg YA
J Psychiatr Res; 2018 Sep; 104():183-191. PubMed ID: 30103065
[TBL] [Abstract][Full Text] [Related]
7. Cognitive correlates of cerebrospinal fluid biomarkers in frontotemporal dementia.
Koedam EL; van der Vlies AE; van der Flier WM; Verwey NA; Koene T; Scheltens P; Blankenstein MA; Pijnenburg YA
Alzheimers Dement; 2013 May; 9(3):269-75. PubMed ID: 22846628
[TBL] [Abstract][Full Text] [Related]
8. Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
Fortea J; Carmona-Iragui M; Benejam B; Fernández S; Videla L; Barroeta I; Alcolea D; Pegueroles J; Muñoz L; Belbin O; de Leon MJ; Maceski AM; Hirtz C; Clarimón J; Videla S; Delaby C; Lehmann S; Blesa R; Lleó A
Lancet Neurol; 2018 Oct; 17(10):860-869. PubMed ID: 30172624
[TBL] [Abstract][Full Text] [Related]
9. A combination of total tau and neurofilaments discriminates between neurodegenerative and primary psychiatric disorders.
Fourier A; Formaglio M; Kaczorowski F; Mollion H; Perret-Liaudet A; Sauvee M; Quadrio I
Eur J Neurol; 2020 Jul; 27(7):1164-1169. PubMed ID: 32243670
[TBL] [Abstract][Full Text] [Related]
10. The Diagnostic Challenge of the Late-Onset Frontal Lobe Syndrome: Clinical Predictors for Primary Psychiatric Disorders Versus Behavioral Variant Frontotemporal Dementia.
Vijverberg EGB; Gossink F; Krudop W; Sikkes S; Kerssens C; Prins N; Stek M; Scheltens P; Pijnenburg Y; Dols A
J Clin Psychiatry; 2017; 78(9):e1197-e1203. PubMed ID: 29099546
[TBL] [Abstract][Full Text] [Related]
11. Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders.
Ducharme S; Dols A; Laforce R; Devenney E; Kumfor F; van den Stock J; Dallaire-Théroux C; Seelaar H; Gossink F; Vijverberg E; Huey E; Vandenbulcke M; Masellis M; Trieu C; Onyike C; Caramelli P; de Souza LC; Santillo A; Waldö ML; Landin-Romero R; Piguet O; Kelso W; Eratne D; Velakoulis D; Ikeda M; Perry D; Pressman P; Boeve B; Vandenberghe R; Mendez M; Azuar C; Levy R; Le Ber I; Baez S; Lerner A; Ellajosyula R; Pasquier F; Galimberti D; Scarpini E; van Swieten J; Hornberger M; Rosen H; Hodges J; Diehl-Schmid J; Pijnenburg Y
Brain; 2020 Jun; 143(6):1632-1650. PubMed ID: 32129844
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Accuracy of MRI and Additional [18F]FDG-PET for Behavioral Variant Frontotemporal Dementia in Patients with Late Onset Behavioral Changes.
Vijverberg EG; Wattjes MP; Dols A; Krudop WA; Möller C; Peters A; Kerssens CJ; Gossink F; Prins ND; Stek ML; Scheltens P; van Berckel BN; Barkhof F; Pijnenburg YA
J Alzheimers Dis; 2016 Jun; 53(4):1287-97. PubMed ID: 27372646
[TBL] [Abstract][Full Text] [Related]
13. Serum neurofilament light chain in behavioral variant frontotemporal dementia.
Steinacker P; Anderl-Straub S; Diehl-Schmid J; Semler E; Uttner I; von Arnim CAF; Barthel H; Danek A; Fassbender K; Fliessbach K; Foerstl H; Grimmer T; Huppertz HJ; Jahn H; Kassubek J; Kornhuber J; Landwehrmeyer B; Lauer M; Maler JM; Mayer B; Oeckl P; Prudlo J; Schneider A; Volk AE; Wiltfang J; Schroeter ML; Ludolph AC; Otto M;
Neurology; 2018 Oct; 91(15):e1390-e1401. PubMed ID: 30209235
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer's disease and frontotemporal disorders in clinical settings.
Eratne D; Loi SM; Li QX; Stehmann C; Malpas CB; Santillo A; Janelidze S; Cadwallader C; Walia N; Ney B; Lewis V; Senesi M; Fowler C; McGlade A; Varghese S; Ravanfar P; Kelso W; Farrand S; Keem M; Kang M; Goh AMY; Dhiman K; Gupta V; Watson R; Yassi N; Kaylor-Hughes C; Kanaan R; Perucca P; Dobson H; Vivash L; Ali R; O'Brien TJ; Hansson O; Zetterberg H; Blennow K; Walterfang M; Masters CL; Berkovic SF; Collins S; Velakoulis D;
Alzheimers Dement; 2022 Nov; 18(11):2218-2233. PubMed ID: 35102694
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ
Hampel H; Toschi N; Baldacci F; Zetterberg H; Blennow K; Kilimann I; Teipel SJ; Cavedo E; Melo Dos Santos A; Epelbaum S; Lamari F; Genthon R; Dubois B; Floris R; Garaci F; Lista S;
Alzheimers Dement; 2018 Apr; 14(4):492-501. PubMed ID: 29328927
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis.
Struyfs H; Niemantsverdriet E; Goossens J; Fransen E; Martin JJ; De Deyn PP; Engelborghs S
Front Neurol; 2015; 6():138. PubMed ID: 26136723
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration.
Scherling CS; Hall T; Berisha F; Klepac K; Karydas A; Coppola G; Kramer JH; Rabinovici G; Ahlijanian M; Miller BL; Seeley W; Grinberg LT; Rosen H; Meredith J; Boxer AL
Ann Neurol; 2014 Jan; 75(1):116-26. PubMed ID: 24242746
[TBL] [Abstract][Full Text] [Related]
18. The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias.
Abu-Rumeileh S; Capellari S; Stanzani-Maserati M; Polischi B; Martinelli P; Caroppo P; Ladogana A; Parchi P
Alzheimers Res Ther; 2018 Jan; 10(1):3. PubMed ID: 29368621
[TBL] [Abstract][Full Text] [Related]
19. Identifying Specific Clinical Symptoms of Behavioral Variant Frontotemporal Dementia Versus Differential Psychiatric Disorders in Patients Presenting With a Late-Onset Frontal Lobe Syndrome.
Dols A; van Liempt S; Gossink F; Krudop WA; Sikkes S; Pijnenburg YA; Stek ML
J Clin Psychiatry; 2016 Oct; 77(10):1391-1395. PubMed ID: 27380626
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum.
Meeter LHH; Vijverberg EG; Del Campo M; Rozemuller AJM; Donker Kaat L; de Jong FJ; van der Flier WM; Teunissen CE; van Swieten JC; Pijnenburg YAL
Neurology; 2018 Apr; 90(14):e1231-e1239. PubMed ID: 29514947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
